Cookson Peirce & Co
UTHR icon

Cookson Peirce & Co’s United Therapeutics UTHR Stock Holding History

Cookson Peirce & Co’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,727
Closed -$1.48M – 378
2026
Q2 		$1.48M Buy
2,727
+302
+12% +$170K 0.05% 183
2026
Q1 		$1.44M Buy
2,425
+1,814
+297% +$903K 0.06% 151
2025
Q4 		$298K Sell
611
-587
-49% -$273K 0.01% 277
2025
Q3 		$502K Buy
1,198
+283
+31% +$95.2K 0.02% 234
2025
Q2 		$263K Buy
+915
New +$273K 0.01% 251
2023
Q1 		– Sell
-4,836
Closed -$1.34M – 260
2022
Q4 		$1.34M Sell
4,836
-360
-7% -$90.9K 0.09% 88
2022
Q3 		$1.09M Buy
5,196
+43
+0.8% +$9.6K 0.08% 98
2022
Q2 		$1.21M Buy
+5,153
New +$1.05M 0.08% 95
2022
Q1 		– Sell
-3,680
Closed -$795K – 249
2021
Q4 		$795K Buy
3,680
+258
+8% +$50.6K 0.04% 125
2021
Q3 		$632K Buy
3,422
+277
+9% +$54.6K 0.04% 137
2021
Q2 		$564K Buy
3,145
+202
+7% +$38.5K 0.04% 146
2021
Q1 		$492K Buy
+2,943
New +$491K 0.03% 126
2015
Q4 		– Sell
-2,925
Closed -$384K – 160
2015
Q3 		$384K Sell
2,925
-1,321
-31% -$212K 0.06% 112
2015
Q2 		$739K Buy
4,246
+40
+1% +$7.2K 0.12% 90
2015
Q1 		$725K Buy
4,206
+530
+14% +$80.8K 0.13% 90
2014
Q4 		$476K Buy
+3,676
New +$474K 0.1% 97
2014
Q2 		– Sell
-37,300
Closed -$3.51M – 164
2014
Q1 		$3.51M Sell
37,300
-1,555
-4% -$159K 0.88% 40
2013
Q4 		$4.39M Buy
+38,855
New +$3.5M 1.16% 29

Other funds holding UTHR

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Cookson Peirce & Co's UTHR Position: Q3 2026 in Review

Cookson Peirce & Co sold out of United Therapeutics (UTHR) in Q3 2026, closing a stake of 2,727 shares — an estimated $1.48M sold.

Cookson Peirce & Co first reported a position in UTHR in Q4 2013 and held it in 18 quarters. The position peaked at $4.39M in Q4 2013. 628 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Cookson Peirce & Co reported no remaining United Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Cookson Peirce & Co sold 2,727 United Therapeutics shares in Q3 2026, an estimated $1.48M.
  • Cookson Peirce & Co first reported a position in United Therapeutics in Q4 2013 and held it in 18 quarters.
  • Cookson Peirce & Co's United Therapeutics position peaked at $4.39M in Q4 2013.
  • 628 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.